Radiation therapy-induced metastasis: radiobiology and clinical implications

BJ Blyth, AJ Cole, MP MacManus, OA Martin - Clinical & experimental …, 2018 - Springer
Radiation therapy is an effective means of achieving local control in a wide range of primary
tumours, with the reduction in the size of the tumour (s) thought to mediate the observed …

[HTML][HTML] New radiotherapy approaches in locally advanced non-small cell lung cancer

M Christodoulou, N Bayman, P McCloskey… - European journal of …, 2014 - Elsevier
Radiotherapy plays a major role in the treatment of patients with locally advanced non-small
cell lung cancer (NSCLC), particularly since most patients are not suitable for surgery due to …

How important is dosimetrist experience for intensity modulated radiation therapy? A comparative analysis of a head and neck case

V Batumalai, MG Jameson, DF Forstner, P Vial… - Practical radiation …, 2013 - Elsevier
Purpose Treatment planning for IMRT is a complex process that requires additional training
and expertise. The aim of this study was to compare and analyze IMRT plans generated by …

[HTML][HTML] Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non …

A van Baardwijk, B Reymen, S Wanders… - European journal of …, 2012 - Elsevier
BACKGROUND: Sequential chemotherapy and individualised accelerated radiotherapy
(INDAR) has been shown to be effective in non-small cell lung cancer (NSCLC), allowing …

Is IMRT superior or inferior to 3DCRT in radiotherapy for NSCLC? A meta-analysis

X Hu, W He, S Wen, X Feng, X Fu, Y Liu, K Pu - PloS one, 2016 - journals.plos.org
Introduction There are no adequate data to determine whether intensity-modulated
radiotherapy (IMRT) is superior to three-dimensional conformal radiotherapy (3DCRT) in the …

Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E (B) US-NA information in addition to PET–CT for delineation?

ST Peeters, C Dooms, A Van Baardwijk… - Radiotherapy and …, 2016 - Elsevier
Abstract Background FDG-PET–CT-based selective lymph node (LN) irradiation is standard
using 3D-conformal techniques for locally advanced NSCLC. With newer techniques …

Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-year results of a prospective study

D De Ruysscher, A van Baardwijk, R Wanders… - Radiotherapy and …, 2019 - Elsevier
Background Stage III non-small cell lung cancer (NSCLC) still has a poor prognosis. Prior
studies with individualized, accelerated, isotoxic dose escalation (INDAR) with 3D-CRT …

Dose escalation for locally advanced lung cancer using adaptive radiation therapy with simultaneous integrated volume-adapted boost

E Weiss, M Fatyga, Y Wu, N Dogan, S Balik… - International Journal of …, 2013 - Elsevier
PURPOSE: To test the feasibility of a planned phase 1 study of image-guided adaptive
radiation therapy in locally advanced lung cancer. METHODS AND MATERIALS: Weekly 4 …

How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?

N Bayman, F Blackhall, P McCloskey, P Taylor… - Lung cancer, 2014 - Elsevier
Latest evidence sets a clear mandate for concurrent chemoradiotherapy as the current
standard of care for inoperable stage III non small cell lung cancer patients with good …

Lung cancer. Radiotherapy in lung cancer: Actual methods and future trends

A Maciejczyk, I Skrzypczyńska… - Reports of practical …, 2014 - journals.viamedica.pl
This survey is performed to update knowledge about methods and trends in lung cancer
radiotherapy. A significant development has been noticed in radiotherapeutic techniques …